SmallCapsOnline Home





-- Access Pharmaceuticals -- ACTV -- Advanced Tissue Sciences, Inc. -- AMBI Inc. -- ARIAD Pharmaceuticals, Inc. -- Cell Therapeutics, Inc. -- CTC Communications + Update 04-22-99 + Initial Opinion + Financial Model -- Cubist Pharmaceuticals, Inc. -- Cypress Bioscience -- CytRx Corp. -- Exigent International, Inc. -- FutureLink Distribution Corp. -- Hemacare Corporation -- Medarex, Inc. -- Valentis, Inc.

To receive immediate notification of research updates, enter your e-mail address here (ex: name@domain.com):

CTC Communications Corp.

CTC Communications Corp. ("CPTL") is a rapidly growing integrated communications provider ("ICP"), offering a comprehensive package of services, including local, long distance, Internet access, frame relay and other data services, on a single integrated bill. CTC currently serves small- and medium-sized businesses in the Northeast and Mid-Atlantic states, operating 25 branch offices with approximately 175 direct sales people and 95 customer service representatives. We believe that CTC's sales and customer service program, honed over 15 years of telephony sales and service as Bell Atlantic's largest agent, is a key competitive advantage, and will continue to result in high access line growth and low customer churn. CTC is currently deploying a state-of-the-art, packet-switched data-centric network, which it calls its Integrated Communications Network ("ICN"). The first switches, advanced ATM+IP switches produced and financed by Cisco Systems, Inc., are currently being deployed in CPTL markets, and we expect CPTL will begin transitioning customers to its network in Summer 1999. Utilization of its own network should enable CPTL to provide its customers with an enhanced package of telephony services, with expanded margins.